BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12361958)

  • 1. Heteromultimerization modulates P2X receptor functions through participating extracellular and C-terminal subdomains.
    Koshimizu TA; Ueno S; Tanoue A; Yanagihara N; Stojilkovic SS; Tsujimoto G
    J Biol Chem; 2002 Dec; 277(49):46891-9. PubMed ID: 12361958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of purinergic P2X receptor activity on ectodomain structure.
    He ML; Zemkova H; Stojilkovic SS
    J Biol Chem; 2003 Mar; 278(12):10182-8. PubMed ID: 12524445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic P2X(2) receptor desensitization depends on coupling between ectodomain and C-terminal domain.
    He ML; Koshimizu TA; Tomić M; Stojilkovic SS
    Mol Pharmacol; 2002 Nov; 62(5):1187-97. PubMed ID: 12391283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons.
    Liu M; King BF; Dunn PM; Rong W; Townsend-Nicholson A; Burnstock G
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1043-50. PubMed ID: 11181939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxyl-terminal splicing enhances physical interactions between the cytoplasmic tails of purinergic P2X receptors.
    Koshimizu TA; Kretschmannova K; He ML; Ueno S; Tanoue A; Yanagihara N; Stojilkovic SS; Tsujimoto G
    Mol Pharmacol; 2006 May; 69(5):1588-98. PubMed ID: 16467187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X(2) ATP-gated channels.
    Boué-Grabot E; Archambault V; Séguéla P
    J Biol Chem; 2000 Apr; 275(14):10190-5. PubMed ID: 10744703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first transmembrane domain of the P2X receptor subunit participates in the agonist-induced gating of the channel.
    Haines WR; Migita K; Cox JA; Egan TM; Voigt MM
    J Biol Chem; 2001 Aug; 276(35):32793-8. PubMed ID: 11438537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes.
    King BF; Townsend-Nicholson A; Wildman SS; Thomas T; Spyer KM; Burnstock G
    J Neurosci; 2000 Jul; 20(13):4871-7. PubMed ID: 10864944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of the C-terminal domain to the control of P2X receptor desensitization.
    Koshimizu T; Koshimizu M; Stojilkovic SS
    J Biol Chem; 1999 Dec; 274(53):37651-7. PubMed ID: 10608821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ectodomain regions contributing to gating, deactivation, and resensitization of purinergic P2X receptors.
    Zemkova H; He ML; Koshimizu TA; Stojilkovic SS
    J Neurosci; 2004 Aug; 24(31):6968-78. PubMed ID: 15295032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors.
    Asatryan L; Popova M; Woodward JJ; King BF; Alkana RL; Davies DL
    Neuropharmacology; 2008 Oct; 55(5):835-43. PubMed ID: 18639563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP analogues with modified phosphate chains and their selectivity for rat P2X2 and P2X2/3 receptors.
    Spelta V; Mekhalfia A; Rejman D; Thompson M; Blackburn GM; North RA
    Br J Pharmacol; 2003 Nov; 140(6):1027-34. PubMed ID: 14581175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
    De Roo M; Boué-Grabot E; Schlichter R
    Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
    Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
    Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of negative residues in the P2X3 ATP receptor ectodomain as structural determinants for desensitization and the Ca2+-sensing modulatory sites.
    Fabbretti E; Sokolova E; Masten L; D'Arco M; Fabbro A; Nistri A; Giniatullin R
    J Biol Chem; 2004 Dec; 279(51):53109-15. PubMed ID: 15475563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
    Lewis CJ; Evans RJ
    Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit arrangement in P2X receptors.
    Jiang LH; Kim M; Spelta V; Bo X; Surprenant A; North RA
    J Neurosci; 2003 Oct; 23(26):8903-10. PubMed ID: 14523092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediators potentiate ATP-gated channels through the P2X(3) subunit.
    Paukert M; Osteroth R; Geisler HS; Brandle U; Glowatzki E; Ruppersberg JP; Gründer S
    J Biol Chem; 2001 Jun; 276(24):21077-82. PubMed ID: 11264291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization.
    Gerevich Z; Zadori Z; Müller C; Wirkner K; Schröder W; Rubini P; Illes P
    Br J Pharmacol; 2007 May; 151(2):226-36. PubMed ID: 17351651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baculovirus expression provides direct evidence for heteromeric assembly of P2X2 and P2X3 receptors.
    Radford KM; Virginio C; Surprenant A; North RA; Kawashima E
    J Neurosci; 1997 Sep; 17(17):6529-33. PubMed ID: 9254665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.